| 林鹏 高伟 丘贺 方芳 魏忠敏.依达拉奉联合银杏达莫治疗2型糖尿病合并急性脑梗塞的临床效果分析[J].现代生物医学进展英文版,2016,16(29):5677-5680. |
| 依达拉奉联合银杏达莫治疗2型糖尿病合并急性脑梗塞的临床效果分析 |
| The Clinical Efficacy Analysis of Edaravone and Yinxingdamo on theTreatment of Type 2 Diabetes Mellitus Complicated with Acute Cerebral Infarction |
| |
| DOI： |
| 中文关键词: 2型糖尿病 急性脑梗塞 临床治疗 疗效分析 |
| 英文关键词: Type 2 diabetes Acute cerebral infarction Clinical treatment Efficacy analysis |
| 基金项目:国家自然科学基金项目（81101085） |
|
| Hits: 750 |
| Download times: 0 |
| 中文摘要: |
| 目的：本研究旨在探究2 型糖尿病合并急性脑梗死的临床疗效。方法：对我市医院门诊及住院部在2014 年1 月至2015 年9
月间收录的358 例2 型糖尿病合并急性脑梗塞患者的治疗情况进行，依照患者治疗方法的差异，将本组患者分成两组，分别是对
照组和观察组，对照组实施常规糖尿病及脑梗塞治疗，观察组在其基础上加用依达拉奉联合银杏达莫治疗，持续治疗3 周后，评
估治疗效果。结果：治疗三周后，两组患者的椎基底动脉血流速度均有明显改善（P＜0.05），观察组的改善程度较对照组更为显著
（P＜0.05）；观察组患者的神经功能缺损评分为（10.96± 2.4）分，对照组为（16.21± 3.1）分，则观察组患者神经功能显著由于对照组
（P＜0.05）；观察组患者临床治疗有效率为95.35%，对照组为72.03%，则观察组治疗有效率显著高于对照组，且具有统计学意义
（P＜0.05）；对照组的平均住院时间为（4.2± 1.3）周，观察组的平均住院时间为（2.8± 0.9）周。结论：对于2 型糖尿病合并急性脑梗
塞患者，在临床综合治疗的基础上加用依达拉奉联合银杏达莫治疗效果显著，能够显著提升患者椎基底动脉的血流速度，改善神
经功能缺损，提高临床治疗效果，具有较大推广应用优势及价值。 |
| 英文摘要: |
| Objective:This study aimed to explore clinical effect for patients with type 2 diabetic with acute cerebral infarction.Methods:We collected 358 patients' treatment condition with type 2 diabetes mellitus complicated with acute cerebral infarction between
January 2014 to September 2015 in the outpatient and inpatient department of our city. This group of patients was divided into two
groups in accordance with the difference in treatment of patients in, namely control group and observation group. Control group carried
to implement conventional diabetes and cerebral infarction treatment. Observation group was treated with edaravone and Yinxingdamo
treatment on its basis, continued treatment for 3 weeks and assessed the therapeutic effect.Results:After treatment for three weeks, the
two groups of patients with vertebral basilar artery blood flow velocity were significantly improved (P<0.05). The degree of improvement
in the observation group was more significant than the control group (P<0.05); Neurological impairment of patients in the observation
group score was (10.96± 2.4) points, and the control group was (16.21± 3.1) points. the neurological impairment of observation
group were significantly better than the control group (P<0.05); clinical observation effective rate of the observation group was 95.35%
compared with 72.03% of the control group, the treatment efficiency of the observation group was significantly higher, and statistically
significant (P<0.05). The average length of hospital stay in the control group was (4.2± 1.3) weeks, which was (2.8± 0.9) weeks in observation
group.Conclusion:For type 2 diabetes patients complicated with acute cerebral infarction, attaching edaravone and Yinxingdamo
treatment has significant effect increasing on the basis of clinical comprehensive treatment, which can significantly enhance patient
vertebral basilar artery blood flow velocity, improve neurological deficit and clinical outcomes, exhibiting great application advantages
and value. |
|
View Full Text
View/Add Comment Download reader |
| Close |
